NYSE:CAH

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$16.3b

Last Updated

2021/06/24 04:14 UTC

Data Sources

Company Financials +

Executive Summary

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. More Details


Snowflake Analysis

6 star dividend payer and good value.


Similar Companies

Share Price & News

How has Cardinal Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CAH is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CAH's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

-1.9%

CAH

-0.002%

US Healthcare

0.5%

US Market


1 Year Return

8.5%

CAH

38.5%

US Healthcare

42.6%

US Market

Return vs Industry: CAH underperformed the US Healthcare industry which returned 38.5% over the past year.

Return vs Market: CAH underperformed the US Market which returned 42.6% over the past year.


Shareholder returns

CAHIndustryMarket
7 Day-1.9%-0.002%0.5%
30 Day1.2%-2.5%1.9%
90 Day-9.0%6.1%7.9%
1 Year12.6%8.5%40.2%38.5%44.9%42.6%
3 Year25.5%11.7%52.0%45.6%64.4%54.1%
5 Year-15.3%-27.9%99.7%85.0%128.3%102.7%

Long-Term Price Volatility Vs. Market

How volatile is Cardinal Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Cardinal Health undervalued compared to its fair value and its price relative to the market?

43.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CAH ($56.28) is trading below our estimate of fair value ($98.99)

Significantly Below Fair Value: CAH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CAH is good value based on its PE Ratio (14.3x) compared to the US Healthcare industry average (20.5x).

PE vs Market: CAH is good value based on its PE Ratio (14.3x) compared to the US market (19.2x).


Price to Earnings Growth Ratio

PEG Ratio: CAH's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: CAH is overvalued based on its PB Ratio (9.1x) compared to the US Healthcare industry average (4x).


Future Growth

How is Cardinal Health forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

-8.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CAH's earnings are forecast to decline over the next 3 years (-8.5% per year).

Earnings vs Market: CAH's earnings are forecast to decline over the next 3 years (-8.5% per year).

High Growth Earnings: CAH's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CAH's revenue (4.5% per year) is forecast to grow slower than the US market (9.5% per year).

High Growth Revenue: CAH's revenue (4.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CAH's Return on Equity is forecast to be very high in 3 years time (259.1%).


Past Performance

How has Cardinal Health performed over the past 5 years?

-39.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CAH has a large one-off loss of $734.0M impacting its March 31 2021 financial results.

Growing Profit Margin: CAH became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: CAH's earnings have declined by 39.9% per year over the past 5 years.

Accelerating Growth: CAH has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CAH has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (59.7%).


Return on Equity

High ROE: Whilst CAH's Return on Equity (64.33%) is outstanding, this metric is skewed due to their high level of debt.


Financial Health

How is Cardinal Health's financial position?


Financial Position Analysis

Short Term Liabilities: CAH's short term assets ($30.4B) exceed its short term liabilities ($25.3B).

Long Term Liabilities: CAH's short term assets ($30.4B) exceed its long term liabilities ($16.8B).


Debt to Equity History and Analysis

Debt Level: CAH's debt to equity ratio (348.5%) is considered high.

Reducing Debt: CAH's debt to equity ratio has increased from 81% to 348.5% over the past 5 years.

Debt Coverage: CAH's debt is well covered by operating cash flow (32.1%).

Interest Coverage: CAH's interest payments on its debt are well covered by EBIT (10.2x coverage).


Balance Sheet


Dividend

What is Cardinal Health current dividend yield, its reliability and sustainability?

3.49%

Current Dividend Yield


Upcoming Dividend Payment

TodayJun 24 2021Ex Dividend DateJun 30 2021Dividend Pay DateJul 15 202115 days from Ex DividendBuy in the next 5 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: CAH's dividend (3.49%) is higher than the bottom 25% of dividend payers in the US market (1.3%).

High Dividend: CAH's dividend (3.49%) is in the top 25% of dividend payers in the US market (3.46%)


Stability and Growth of Payments

Stable Dividend: CAH's dividends per share have been stable in the past 10 years.

Growing Dividend: CAH's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (49.5%), CAH's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CAH's dividends in 3 years are forecast to be well covered by earnings (30.4% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Mike Kaufmann (57 yo)

3.42yrs

Tenure

US$14,217,127

Compensation

Mr. Michael C. Kaufmann, also known as Mike, serves as Chief Executive Officer and Director of Cardinal Health, Inc. since January 1, 2018. Mr. Kaufmann served as the Chief Financial Officer at Cardinal He...


CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD14.22M) is about average for companies of similar size in the US market ($USD11.28M).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CAH's management team is considered experienced (2.3 years average tenure).


Board Members

Experienced Board: CAH's board of directors are not considered experienced ( 3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Cardinal Health, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cardinal Health, Inc.
  • Ticker: CAH
  • Exchange: NYSE
  • Founded: 1979
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$16.330b
  • Shares outstanding: 290.15m
  • Website: https://www.cardinalhealth.com

Number of Employees


Location

  • Cardinal Health, Inc.
  • 7000 Cardinal Place
  • Dublin
  • Ohio
  • 43017
  • United States

Listings


Biography

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharma...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/24 04:14
End of Day Share Price2021/06/23 00:00
Earnings2021/03/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.